Clinical Trial

Food and Fitness With Medicine (FFWM)

Study acronym: FFWM
Recruiting
View on ClinicalTrials.gov →
Summary
Food and Fitness with Medicine (FFWM) is a 24-week randomized controlled trial (RCT) enrolling 200 post-menopausal women (PMW) with stage 2 cardio-kidney metabolic (CKM) syndrome and type-2 diabetes (T2D) within 6 weeks of initiating glucagon-like peptide-1 receptor agonist (GLP-1RAs) to: 1. Examine discontinuation rates of GLP-1RAs (primary outcome); 2. Compare change in American Heart Association (AHA) PREVENT scores (secondary outcome); and 3. Examine the effects of FFWM on biologic mechanisms responsive to weight loss and cardiovascular health (CVH) including dermal carotenoids, body composition and metabolite biomarkers.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-17; most recent amendment 2026-02-20.
Status change: Not Yet Recruiting → Recruiting 2026-01-13
Trial Details
NCT Number NCT07027995
Lead Sponsor Ohio State University
Collaborators: American Heart Association
Conditions Cardiovascular Kidney Metabolic Syndrome, Type 2 Diabetes
Enrollment 200 participants
Start Date 2026-01-14
Primary Completion 2028-11 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-23